Psilocybin Therapies

Psyched: 5-MeO-DMT For Depression, Utah Hospitals Providing Therapy, Elon Musk And Meta's Influence
Indiana Governor Signs Health Bill Including State Funds For Psilocybin Research
FDA Grants Cybin Breakthrough Therapy Status For Major Depression Psilocybin Therapy, Company Announces Positive Clinical Data & Canadian $150M Private Placement
Indiana Governor Signs Health Bill Including State Funds For Psilocybin Research
FDA Grants Cybin Breakthrough Therapy Status For Major Depression Psilocybin Therapy, Company Announces Positive Clinical Data & Canadian $150M Private Placement
Truffles To Market: Red Light Holland Wants To Develop Psilocybin API At Scale
Compass Pathways Shows Robust 2023 Year-End Results, Embraces Clinical Milestones For Psilocybin As Depression Treatment

Psilocybin Therapies Recent News

Psyched: Suggestibility And Psychedelics' Effects, EU's $7M Research Fund, Australia's Treatment Delivery, BZ Podcast And More
New study finds suggestibility plays a role in antidepressant effects of psilocybin therapy. EU invests 6.5M euros in psychedelics for pulmonary disorder, MS, ALS, and Parkinson's. Australian psychiatrists provide first psychedelic-assisted treatments in 50 years.
Psychedelics Headlines: Magic Mushrooms For Sexual Wellbeing, The DEA's Stance, The Therapist's Role & More
Welcome to Benzinga's weekly psychedelics news roundup. We have pulled together several must-read news items from the last week of December 2023 and the first of January 2024. 
The Fate Of Psilocybin's Rescheduling Petition: DEA Retains Control As Federal Court Confirms Case Jurisdiction
Dr. Sunil Aggarwal’s long-standing battle for the federal rescheduling of psilocybin for end-of-life cancer patients just hit another obstacle.
Law Enforcement Cracks Down On Controlled Substances In Connecticut & Vancouver, Various Arrests Made
Following a potential drug-dealing lead, a joint drug task force with federal, state and local law enforcement authorities raided a property in Burlington, Connecticut and found large bags of psilocybin mushrooms worth around $8.5 million.
Psilocybin Eases Psychological Distress From Childhood Trauma, New Survey Suggests
Recently published findings from a Canada-based survey conducted by U.S. and Canadian universities and completed by 1,249 participants reflect that using psilocybin can help ease psychological distress from adverse childhood experiences. 
Optimi Health Will Supply Psychedelics To Canada's SAP, Secures CA$1M Private Financing
Health Canada has approved an amendment to Optimi Health’s (OTCQX: OPTHF) dealer's license, effectively allowing the company to supply MDMA and psilocybin drugs to the country’s Special Access Program (SAP.) 
Second Psychedelics Merger Of The Week? Silo Wellness To Buy Jamaica-Based Business For $31.9M
Silo Wellness (OTCQB: SILFF) has confirmed its intention to acquire all issued and outstanding securities of NUGL Inc./Kaya Group (OTC Pink: NUGL) in an arms-length transaction valued at $31.9 (CA$43.3) million.
Cracking The Code Of Healing: Can Trained Coders Observe Therapeutic Moments In Psilocybin Therapy?
Findings from a new study conducted by novel therapeutics cancer firm Sunstone Therapies and the University of Vermont’s Conversation Lab show the feasibility of trained human coders to identify observable markers of therapeutic connection during psilocybin administration within Psychedelic-Assisted Therapy (PAT.)
Beckley Retreats, Heroic Hearts And Imperial College's Psychedelics Research Into Veteran Suicides
Jamaica and Netherlands-based wellbeing company Beckley Retreats is furthering its commitment to veteran suicide prevention through a renewed strategic partnership with the Heroic Hearts Project and Imperial Coll
Psilocybin For IBS Gets FDA Nod To Begin Clinical Trials At Mass. General Hospital
Tryp Therapeutics’ (OTCQB: TRYPF) latest Investigational New Drug (IND) application was approved by the FDA, enabling the company to begin Phase 2a clinical trials at the Massachusetts General Hospital (MGH) on the effects of psilocybin-assisted psychotherapy for adults with Irritable B
COMPASS Pathways Secures Up To $50M In Term Loan Facility With Hercules Capital
Mental health psychedelics biotech company COMPASS Pathways (NASDAQ: CMPS) received funding for its COMP360 Phase 3 program in Treatment-Resist
UK Greenlights Phase 2 Clinical Trial On Mindset Pharma's Psilocin Drug For Major Depression
Drug discovery company Mindset Pharma (OTCQB: MSSTF) received approval from the U.K.
MA, FL And OH Psychedelics Scientists And Educators' Latest Research And Views
Along with a growing scientific corpus supporting the therapeutic potential of psychedelics, several states and most noticeably Massachusetts are seeing the decriminalization of natural substances via local measures. 
Hollywood's Psychedelics Craze, Is Drew Barrymore Joining The Trend?
Former child star and one of the beloved Charlie’s Angels, Drew Barrymore hinted that she would consider MDMA or psilocybin therapy “as a way to get to some state where I could see things in a different way.” As hostess of The Drew Barrymore Show, she encourages guests to open up emotionally. 
Doing Some Microscopic Research On Mushrooms? This Company Is Offering Psilocybin Spores
Denver-based Shaman Mushroom Spores is offering high-quality psilocybe cubensis mushroom spore syringes exclusively available for research purposes.
This Company's Psilocybin-Based Non Hallucinogenic Compound Heads Toward Clinical Studies
Biopharma company Psilera Inc. announced it has selected its first clinical candidate, a novel drug sharing several of psilocybin’s properties but without the hallucinogenic effects.
The Psychedelic Mushrooms Market; Between Legitimate Harvesting And Illegal Retail Sales
While psychedelics reform is clearly gaining momentum, not only in the U.S. but notably in places like Australia and less so Canada. The fact is, all compounds remain currently Schedule I drugs (or equivalents) and thus federally illegal in many countries including the U.S.
New Psilocybin Chocolate Bar By Vertical Cannabis And Psychedelics Company
Holistic wellness company Kaya Group’s (OTC: NUGL) subsidiary Kaya Extracts is expanding its product offerings with two new psychedelic mushroom chocolates, available in Jamaica's legal psilocybin market. 
Mia Khalifa Joins Magic Mushrooms Company, Here's What She'll Be Doing
Canada-based mushrooms producer Red Light Holland Corp. (OTCQB: TRUFF) has launched a collaboration with former adult film performer and social media star Mia Khalifa.
Lucy Scientific Secures First Delivery Of Psilocybin To Israel Following DMT & 5-MeO-DMT
Lucy Scientific Discovery Inc. (NASDAQ: LSDI), a Canada-based psychedelics manufacturing company, has inked its first commercial sale to the prestigious Hadassah BrainLabs, also known as the Center for Psychedelics Research at the Hadassah Medical Center at Hebrew University in Jerusalem. 
Red Light Holland's Q3 2023 Financials: Expanded Farms Division, Home Grow Kits & Revenue Increase
Ontario-based mushrooms producer Red Light Holland Corp. (OTCQB: TRUFF) filed its interim financial results for the third fiscal quarter of 2023 -three and nine months- ended December 31, 2022.
This Midwestern State Rejoins The Magic Mushroom Therapy Discussion Club With Revised Bill
Missouri Rep.
Utah Group Launches Campaign To Legalize Magic Mushrooms For Therapeutic & Academic Purposes
The new non-profit, Utah Mushroom Therapy, recently launched a campaign to support the legalization of magic mushrooms, also known as psilocybin.

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga

© 2024 Benzinga | All Rights Reserved